HST
47
-2
AIZ
61
-7
AIG
56
-6
GPC
51
-5
AVY
43
-3
FITB
66
-2
BA
56
2
MCHP
65
-2
LH
42
-7
DRI
60
2
MUR
39
-4
LMT
35
-4
IR
74
-3
EOG
47
-3
EA
50
-2
F
51
-3
KMX
58
6
AA
56
2
ALL
48
-3
GILD
52
-3
HST
47
-2
AIZ
61
-7
AIG
56
-6
GPC
51
-5
AVY
43
-3
FITB
66
-2
BA
56
2
MCHP
65
-2
LH
42
-7
DRI
60
2
MUR
39
-4
LMT
35
-4
IR
74
-3
EOG
47
-3
EA
50
-2
F
51
-3
KMX
58
6
AA
56
2
ALL
48
-3
GILD
52
-3
Financhill
Back

RxSight Stock Price Chart

FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here
Sell
30

RXST
RxSight

Last Price:
$13.36
Seasonality Move:
9.21%

7 Day Trial

ALL ACCESS PASS

$ 7

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RXST is experiencing buying pressure, which is a positive indicator for future bullish movement.

RxSight Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 13.75 Sell
20-day SMA: 14.35 Sell
50-day SMA: 19.22 Sell
200-day SMA: 37.47 Sell
8-day EMA: 13.72 Sell
20-day EMA: 14.82 Sell
50-day EMA: 18.99 Sell
200-day EMA: 32.66 Sell

RxSight Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.57 Sell
Relative Strength Index (14 RSI): 35.32 Sell
Chaikin Money Flow: 652766 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.7 - 15.08) Sell
Bollinger Bands (100): (17.98 - 33.94) Sell

RxSight Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for RxSight Stock

Is RxSight Stock a Buy?

  • RxSight share price is 13.24 while RXST 8-day simple moving average is 13.75, which is a Sell signal.
  • The stock price of RXST is 13.24 while RxSight 20-day SMA is 14.35, which makes it a Sell.
  • RxSight 50-day simple moving average is 19.22 while RXST share price is 13.24, making it a Sell technically.
  • RXST stock price is 13.24 and RxSight 200-day simple moving average is 37.47, creating a Sell signal.

RXST Technical Analysis vs Fundamental Analysis

Sell
30
RxSight (RXST) is a Sell

Is RxSight a Buy or a Sell?

  • RxSight stock is rated a Sell
    The current RxSight [RXST] share price is $13.24. The Score for RXST is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.

RxSight Stock Info

Market Cap:
538M
Price in USD:
13.24
Share Volume:
1.2M

RxSight 52-Week Range

52-Week High:
64.50
52-Week Low:
12.53
Sell
30
RxSight (RXST) is a Sell

RxSight Share Price Forecast

  • What is the RxSight stock price today?
    The RxSight stock price is 13.24 USD today.
  • Will RXST stock go up or go down?
    RxSight> share price is forecast to RISE/FALL based on technical indicators
  • Is RxSight overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, RxSight is overvalued.

Is RxSight Stock a Buy?

  • RxSight share price is 13.24 while RXST 8-day exponential moving average is 13.72, which is a Sell signal.
  • The stock price of RXST is 13.24 while RxSight 20-day EMA is 14.82, which makes it a Sell.
  • RxSight 50-day exponential moving average is 18.99 while RXST share price is 13.24, making it a Sell technically.
  • RXST stock price is 13.24 and RxSight 200-day simple moving average is 32.66, creating a Sell signal.

Fundamental Analysis of RxSight

Is RxSight a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.02 per share, and an increase next year of $0.19 per share.

Technical Analysis of RxSight

Should I short RxSight stock?

  • RXST Moving Average Covergence Divergence (MACD) indicator is -1.57, suggesting RxSight is a Sell
  • RxSight Relative Strength Index (RSI) is 35.32, which suggest RxSight is oversold
  • The Bollinger Bands (25) for RxSight is (13.7 - 15.08), which suggest RxSight is a Sell
  • The Bollinger Bands (100) for RxSight is (17.98 - 33.94), which suggest RxSight is a Sell

* RxSight stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.